EUVIMEDEUVIMED entdecken
Crossref

Evaluation of the current status, significance, and availability of prostate MRI und MRI guided biopsy in Germany

Tim Ullrich, Matthias Boschheidgen, Caroline Marie Schweyen, Tobias Franiel, Birte Valentin iD, Michael Quentin, Dirk Blondin, Sascha Kaufmann, Alexandra Ljimani iD, Jan Philipp Radtke, Peter Albers, Gerald Antoch und 1 weitere

RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · 01.08.2025 · 197 (08) · 945-952

DOI: 10.1055/a-2416-1343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, erschienen am 01.08.2025. Verfasst von Tim Ullrich und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, University Dusseldorf, Medical Faculty, Dusseldorf, Germany. Hauptthemen laut MEDLINE: Image-Guided Biopsy, Prostatic Neoplasms, Magnetic Resonance Imaging, Prostate. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Evaluation of the current status, significance and availability of multiparametric prostate MRI and MRI-guided biopsy in Germany. A voluntary web-based questionnaire with 26 distinct items was emailed to members of the German Radiological Society (DRG) and the Professional Association of German Radiologists (BDR). The questions referred to personal qualification, acquisition, quality, and management of prostate MRI, and assessment of the importance of the method. In total 182 questionnaires were captured from all 10 german postal regions (over 60% of the university hospitals, almost 50% of the maximum care hospitals and approx. 12% of the practices or medical service centers). 43% of the respondents had a Q1 or Q2 quality certificate from the DRG, 10% had a certificate from the BDR, respectively. The majority (90%) criticized inadequate reimbursement of the examination. In 47% MRI cases were discussed in an interdisciplinary tumor board, in 44% case discussions happened rarely, and 12% never had interdisciplinary discussions. On a scale from 0–100 (0%: low; 100%: high) the estimation of the clinical relevance of prostate MRIs received an average of 84% (± 16%) and the estimated approval by urologists was 75% (± 21%). Lacking clinical feedback (59%) and clinical information (42%) were perceived as the largest problems. In this representative survey the respondents estimated multiparametric MRI of the prostate as highly diagnostic and relevant with an increased approval by urologists. There is still a perceived need for continuous professional education of the method for urologists and for more widespread coverage of fusion biopsy. Prostate MRI is currently primarily offered by high volume centers. Current challenges are particularly insufficient interdisciplinary communication and inadequate reimbursement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Image-Guided BiopsyProstatic NeoplasmsMagnetic Resonance ImagingProstateMagnetic Resonance Imaging, InterventionalMultiparametric Magnetic Resonance ImagingHumansMaleGermanySurveys and Questionnaires

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Radiology, University Dusseldorf, Medical Faculty, Dusseldorf, Germany.
  • Department of Diagnostic and Interventional Radiology, Jena University Hospital, Jena, Germany.
  • Department of Radiology, Vascular Radiology and Nuclear Medicine, Städtische Kliniken Mönchengladbach GmbH, Mönchengladbach, Germany.
  • Diagnostic and Interventional Radiology, Siloah St. Trudpert Klinikum, Pforzheim, Germany.
  • Department of Urology, University Dusseldorf, Medical Faculty, Dusseldorf, Germany.
  • Department of Diagnostic, Interventional Radiology and Nuclear Medicine, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany.

ORCID-Profile: Birte Valentin, Alexandra Ljimani, Lars Schimmöller

Zitieren

APA

Ullrich, T., Boschheidgen, M., Schweyen, C. M., Franiel, T., Valentin, B., Quentin, M., Blondin, D., Kaufmann, S., Ljimani, A., Radtke, J. P., Albers, P., Antoch, G., & Schimmöller, L. (2025). Evaluation of the current status, significance, and availability of prostate MRI und MRI guided biopsy in Germany. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 197(08), 945-952. https://doi.org/10.1055/a-2416-1343

Vancouver

Ullrich T, Boschheidgen M, Schweyen CM, Franiel T, Valentin B, Quentin M, et al. Evaluation of the current status, significance, and availability of prostate MRI und MRI guided biopsy in Germany. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 2025;197(08):945-952. doi:10.1055/a-2416-1343

BibTeX
@article{Ullrich2025,
  author = {Ullrich, Tim and Boschheidgen, Matthias and Schweyen, Caroline Marie and Franiel, Tobias and Valentin, Birte and Quentin, Michael and Blondin, Dirk and Kaufmann, Sascha and Ljimani, Alexandra and Radtke, Jan Philipp and Albers, Peter and Antoch, Gerald and Schimmöller, Lars},
  title = {Evaluation of the current status, significance, and availability of prostate MRI und MRI guided biopsy in Germany},
  journal = {RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren},
  year = {2025},
  volume = {197},
  number = {08},
  pages = {945--952},
  doi = {10.1055/a-2416-1343}
}
Kostenlos starten →